BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3153225)

  • 1. Fungal pneumonias masquerading as thromboses during induction therapy of acute lymphoblastic leukemia.
    Pearson AD; Nesbit ME; Darbyshire PJ; Mott MG
    Pediatr Hematol Oncol; 1986; 3(2):153-7. PubMed ID: 3153225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow necrosis and thrombotic complications in childhood acute lymphoblastic leukemia.
    Eguiguren JM; Pui CH
    Med Pediatr Oncol; 1992; 20(1):58-60. PubMed ID: 1727213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases.
    Trobisch A; Marterer R; Gorkiewicz G; Flaschberger S; Lackner H; Seidel M; Sperl D; Karastaneva A; Kohlmaier B; Egger M; Urban C; Benesch M; Strenger V
    Support Care Cancer; 2020 May; 28(5):2157-2161. PubMed ID: 31410599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.
    Salonen JH
    Acta Biomed; 2006; 77 Suppl 2():28-31. PubMed ID: 16918065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
    Yamamoto M; Hori T; Igarashi K; Iesato K; Saito M; Miyanishi K; Kikuchi N; Fujita H; Tsutsumi H
    Int J Hematol; 2018 Apr; 107(4):390-391. PubMed ID: 29181701
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
    Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
    Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
    Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
    Appel IM; Hop WC; Pieters R
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
    Gururangan S; Horner M; Rodman JH; Marina NM
    Med Pediatr Oncol; 1994; 22(6):414-6. PubMed ID: 8152404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group.
    Gugliotta L; Mazzucconi MG; Leone G; Mattioli-Belmonte M; Defazio D; Annino L; Tura S; Mandelli F
    Eur J Haematol; 1992 Aug; 49(2):63-6. PubMed ID: 1397242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chorea, eosinophilia, and lupus anticoagulant associated with acute lymphoblastic leukemia.
    Schiff DE; Ortega JA
    Pediatr Neurol; 1992; 8(6):466-8. PubMed ID: 1476578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the EEG background activity of children with acute lymphoblastic leukemia during cytotoxic therapy.
    Lichter-Konecki U; Benninger C; Brandeis WE; Matthis P; Scheffner D
    Pediatr Hematol Oncol; 1987; 4(1):77-85. PubMed ID: 3152916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    Sato Y; Ito R; Saito T; Suto Y; Tateoka N; Onodera N; Ikeda Y; Ito E; Miyano T; Tachibana N
    Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased factor VIII activity and dural sinus thrombosis.
    Celkan T; Ozkan A; Apak H; Kuruoglu S; Yuksel L; Yildiz I
    Med Pediatr Oncol; 2002 Jul; 39(1):71-2. PubMed ID: 12116089
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Buchanan GR; Rivera GK; Pollock BH; Boyett JM; Chauvenet AR; Wagner H; Maybee DA; Crist WM; Pinkel D
    Cancer; 2000 Mar; 88(5):1166-74. PubMed ID: 10699908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Second cessation of therapy in children with acute lymphoblastic leukemia].
    Rokicka-Milewska R; Derulska D; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Duczmal B; Jakowicka M
    Acta Haematol Pol; 1992; 23(1):43-7. PubMed ID: 1615750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 20. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
    Nachman J; Sather HN; Gaynon PS; Lukens JN; Wolff L; Trigg ME
    J Clin Oncol; 1997 Jun; 15(6):2222-30. PubMed ID: 9196134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.